ARCHIVES

In Congress: Time Running out On Effort To Double Market Exclusivity Term

This article is from The Cancer Letter archive.

Vol. 23 No. 43 | November 7, 1997

Download PDF Visit The Full Archive

Related Articles

US Oncology Clarifies Role of Pharmacy Committee

January 24, 2003

Time-Out For A New Sense Of Cooperation, Urgency.

January 21, 2000

NCI Appropriations Still Hung Up

September 30, 1977

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990

Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study

June 21, 2002

NCI CTEP Approved Trials For the Month of April

April 26, 2013